---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-001185"
form_type: "8-K"
ticker: "COYA"
cik: "0001835022"
company_name: "Coya Therapeutics, Inc."
filed_at: "2023-01-25T23:59:59+00:00"
generated_at: "2026-06-20T09:46:19.695106+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Coya Therapeutics issues 237,804 more shares through partial IPO over-allotment exercise

## Summary
- Sold 237,804 shares of common stock and warrants for 145,000 shares upon partial over-allotment exercise, closing January 25, 2023.
- Total offering: 3,287,804 shares and warrants for 1,670,000 shares; gross proceeds of approx. $16.4 million.
- Issued underwriters an additional five-year warrant to purchase 16,646 shares at $6.25 per share.
- Chardan Capital Markets and Newbridge Securities acted as joint book-running managers; Joseph Gunnar as co-manager.

## SEC filing metadata
- accession: 0000950170-23-001185
- form_type: 8-K
- ticker: COYA
- cik: 0001835022
- company_name: Coya Therapeutics, Inc.
- filed_at: 2023-01-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835022/000095017023001185/0000950170-23-001185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835022/000095017023001185/coya-20230125.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-001185
- JSON: https://secwatch.observer/filing/0000950170-23-001185.json
- Plain text: https://secwatch.observer/filing/0000950170-23-001185.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.